N/A
Completed N=157
Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting
Source: ClinicalTrials.gov NCT02096835 ↗Enrolled (actual)
157
Serious AEs
0.0%
Results posted
Apr 2015
Primary outcomePrimary: Number of Participants Experiencing Postoperative Nausea and Vomiting in 24h Postoperatively — 14; 14; 25 participants — p=0.021
Summary
The purpose of this study is to access the effect of TEAS of P6 in the prevention of PONV in women scheduled for gynecologic laparoscopic surgery with general anesthesia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Experiencing Postoperative Nausea and Vomiting in 24h Postoperatively |
14; 14; 25 | 0.021 sig |
| SECONDARY Number of Participants Experiencing Postoperative Nausea in 24h Postoperatively |
14; 14; 25 | 0.021 sig |
| SECONDARY Number of Participants Experiencing Postoperative Vomiting in 24h Postoperatively |
9; 8; 12 | 0.503 |
Eligibility Criteria
Inclusion Criteria
- American Society of Anesthesiologists (ASA) physical status I or II
- aged between 18 to 60yr
- scheduled for elective gynecological laparoscopic surgery requiring general anesthesia
Exclusion Criteria
- pregnancy or breastfeeding
- mental retardation
- psychiatric or neurological disease
- use of antiemetics, emetogenic drugs, opioids or glucocorticosteroids within 3 days prior to surgery
- known allergy to tropisetron or dexamethasone
- nausea and/or vomiting within 24 hr prior to surgery
- implantation of a cardiac pacemaker, cardioverter, or defibrillator
- any skin problem at the acupoint stimulation area
Data sourced from ClinicalTrials.gov (NCT02096835). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.